Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342091 · ClinicalTrials.gov registry record · NA
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04342091: Completed NA study, sponsored by Yale University.
NCT04342091 is a NA study that has completed, run by Yale University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04342091, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.
Primary Outcome
Total number of hairs over an area of 1cm\^2
Interventions
- DEVICE SOL Nova Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
What the finished NCT04342091 record still lists
NCT04342091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which SOL Nova Device is the first listed.
NCT04342091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04342091 about?
NCT04342091 is a clinical study titled "Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling". To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.
What is the current status of trial NCT04342091?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-04-09. Estimated completion is 2022-04-08.
What interventions are being tested in trial NCT04342091?
The interventions under investigation include: SOL Nova Device (DEVICE).
Who is sponsoring clinical trial NCT04342091?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04342091's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI